findmyKOL

Charles Croft, MD, FACP, FACC

Basic profile

Children's Medical Center

ORCIDNone on fileNPI
RegionMelbourne, FL · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2004Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Charles Croft is a Cardiology physician affiliated with Children's Medical Center. OpenAlex indexes 28 publications with 1,715 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
28publications

Distinct works indexed by OpenAlex.

1,715citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
42companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1402 Oak St
Melbourne, FL 329013113

Telephone

321-722-3288

Provider last certified this registry record 2 Oct 2025.

View the NPPES registry record

Industry payments

42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    86.6%
    Adenosine Receptor Agonist31.7%
    Adenosine97%Regadenoson3%
    Part B, office-administered56 patients
    Beta blocker13.8%
    Metoprolol Succinate38%Metoprolol Tartrate22%Carvedilol13%Sotalol12%Labetalol Hcl10%Atenolol5%
    Part D146 patients

    + 19 more classes in this area

  • Blood & clotting

    11.2%
    Factor Xa inhibitor5.7%
    Eliquis65%Xarelto35%
    Part D92 patients
    P2Y12 inhibitor4.2%
    Clopidogrel94%Prasugrel Hcl4%Brilinta3%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    2.2%
    SGLT2 inhibitor1.4%
    Jardiance84%Farxiga16%
    Part D<11 patients
    Potassium supplement0.5%
    Potassium Chloride100%
    Part D17 patients

    + 1 more class in this area

Where care is delivered (Part B)22.9% facility · 77.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”